Anzeige
Mehr »
Freitag, 13.03.2026 - Börsentäglich über 12.000 News
Dieser 37-Mio.-€-Goldentwickler sitzt auf einem möglichen $2-Milliarden-Projekt!!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Investing.com

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
DoGRAIL names Josh Ofman as CEO, Bob Ragusa to retire June 1
DoAxcelis names David Ryzhik interim CFO amid leadership change
DoCPKC adds 14 rail-served industrial sites across North America
DoConstellium authorizes $300 million share buyback program
DoiRhythm appoints UnitedHealth executive to board
DoPAR Technology plans $225M convertible notes offering
DoFairview Health Services selects Workday for HR and finance systems
DoLaird Superfood completes $38.5M Navitas acquisition
DoJefferies reiterates Nike stock Buy rating citing wholesale recovery
DoJefferies reiterates Dollar General stock rating citing Q4 beat
DoWolfe Research reiterates Atlassian stock rating on cost cuts
DoBofA cuts Vivid Seats stock price target on near-term pressures
DoCanaccord reiterates Joby Aviation stock rating on testing progress
DoChardan reiterates Orchestra BioMed stock rating on trial focus
DoVita Coco stock price target raised to $70 by Evercore ISI
DoGLJ Research cuts Tesla stock rating on robotaxi safety concerns
DoJefferies says Dick's Sporting Goods results boost Nike stock outlook
DoBTIG reiterates G-III Apparel stock rating, cuts FY27 EPS estimate
DoClear Street lowers Montauk Renewables stock price target on margin miss
DoLeerink reiterates Evommune stock rating after conference chat
DoLeerink Partners reiterates Ardelyx stock rating on pipeline progress
DoJefferies raises Dick's Sporting Goods stock price target to $210
DoBofA Securities reiterates Baidu stock rating citing AI growth
DoFull Truck Alliance stock rating reiterated at Morgan Stanley
DoJefferies reiterates Buy on Novavax stock, cites adjuvant platform